Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients
Polypharmacy, Adverse Drug Reaction
About this trial
This is an interventional prevention trial for Polypharmacy focused on measuring Drug Utilization Review, Aged, Aged, 80 and over, Primary Health Care
Eligibility Criteria
Inclusion Criteria:
- primary health care center in Stockholm County
- authorized by Stockholm County Council since at least 3 years
- at least 5% of patients attributed to primary health care center are 65 years and older
- primary health care center takes care of at least 10 home care patients
Exclusion Criteria:
- less than 3000 patients listed in primary health care center
- primary health care centers where researchers carrying out the present study work
Sites / Locations
- Centre for Family Medicine, Dept of Neurobiology, Care sciences and Society, Karolinska Institutet
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Educational intervention
Delayed educational intervention
Primary health care centers (PHCC) in the intervention group will be visited twice by a pharmacist within a period of three months. At the first visit, an educational intervention will focus on two properties: on the one hand, feed-back of actual patient data of the PHCC illustrating the primary-health-care-specific characteristics of inappropriate prescribing in the elderly patient will be given. Education of relevant subjects will be given in relation to detected problems. On the other hand, a clinical routine regarding the performance of drug utilization reviews will be developed in cooperation with the health care providers. At the second visit 3 months later, the developed concept will be critically reviewed and eventually developed further.
Primary health care centers in the delayed intervention group will receive the same intervention as described above with 9 months delay.